Jane Street
ACHV icon

Jane Street’s Achieve Life Sciences ACHV Stock Holding History

Jane Street’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Buy
+203,900
New +$972K ﹤0.01% 5931
2026
Q1 		– Sell
-13,600
Closed -$67.6K – 11409
2025
Q4 		$67.6K Sell
13,600
-61,300
-82% -$267K ﹤0.01% 10384
2025
Q3 		$236K Buy
+74,900
New +$206K ﹤0.01% 9364
2024
Q3 		– Sell
-20,000
Closed -$94K – 9484
2024
Q2 		$94K Buy
+20,000
New +$96.4K ﹤0.01% 8750

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Jane Street's ACHV Position: Q2 2026 in Review

Jane Street reduced its Achieve Life Sciences (ACHV) stake by 71% in Q2 2026, selling an estimated $602K and leaving 50,456 shares worth $329K. The position accounts for ﹤0.01% of the portfolio, ranked #9012.

Jane Street first reported a position in ACHV in Q2 2013 and has held it in 8 quarters since. The position peaked at $1.9M in Q4 2025. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Jane Street held 50,456 shares of Achieve Life Sciences worth $329K as of Q2 2026.
  • Jane Street sold 126,144 Achieve Life Sciences shares in Q2 2026, an estimated $602K.
  • Achieve Life Sciences made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #9012 holding.
  • Jane Street first reported a position in Achieve Life Sciences in Q2 2013 and has held it in 8 quarters since.
  • Jane Street's Achieve Life Sciences position peaked at $1.9M in Q4 2025.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.